期刊文献+

双功能抗体介导结肠癌细胞杀伤效应的研究

Bispecific McAb Mediated Tumor Growth Inhibition in Colonic Cancer
下载PDF
导出
摘要 目的:研究抗CD3/抗TNP双功能抗体与TNP化抗癌胚抗原(CEA)McAb结合,在裸鼠体内对结肠癌细胞的杀伤作用。方法:将抗癌胚抗原单抗TNP化,TNP化后的抗CEA单抗(TNP-CEA)、抗CD3/抗TNP双功能抗体、人淋巴细胞及结肠癌细胞CL187接种于裸鼠体内,计算肿瘤生长体积,观察成瘤率。结果:双功能抗体能够介导PBLs对CL187细胞的杀伤作用。结肠癌细胞CL187的成瘤能力受到抑制,成瘤率为0/4。结论:此双功能抗体在免疫治疗中具有潜在的应用价值。 Objective:To study in vivo the effects of the bispecific antibody(BsAb)com-bined with TNP-CEA to kill the colonic cells in nude mice.Methods:The anti-CEA antibody was crosslinked with TNP.TNP-CEA、anti-CD 3 /anti-TNP、PBLs and CL187were injected into nudemice to proceeded with tumor growth inhibition test in vivo and to observed the formed tu-mor ratio.Results:The bispecific antibody could induce P BLs to cytotoxic test of colonic cells in vivo.Tumor growth was inbibited and formed tumor ratio was0/4.Conclusion:The bispecific McAb has potential Value in the immuno-biotherapy of tumors.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2003年第3期214-216,共3页 Chinese Journal of Clinical Oncology
基金 北京市自然科学基金项目资助(7932002)
关键词 结肠肿瘤 细胞系 双功能抗体 三硝基苯 Colonic neoplasms cells Bispecific antibody Trinitrobenzene
  • 相关文献

参考文献10

  • 1[1]Robert B, Mach JP, Mani JC, et al. Cytokine targeting in tumors using a bispecific antibody directed against carcinombryonic antgen and rumor necrosis factor alpha [J]. Cancer Res,1996,56(20):4758~4765
  • 2万文徽,高学硕,张宏,董志伟.双功能抗体介导胃癌杀伤效应的研究[J].中华肿瘤杂志,2001,23(4):285-288. 被引量:2
  • 3[3]Donohue JH, Ramsey PS, Kerr LA, et al. Enhanced in Vitro lysis of human ovarian carcinomas with activated peripheral blood lymphocytes and bifunctional immune heteroaggregates [J]. Cancer Res,1990, 50(15): 6508~6514
  • 4[4]De Gast GC, Van de Winkel JGJ, Bast BEJEG. Clinical perspectives of bispecific antibodies in cancer [J]. Cancer Immunol Immunother, 1997, 45:121~123
  • 5[5]Porter LE, Nelson H, Gecim IE, et al. T cell activation and regargeting using staphylococcal enterotoxin B and bispecific antibody: An effective in vivo anti-tumor strategy [J]. Cancer Immunol Immunother, 1997, 45:180~183
  • 6[6]Wooldridge JE, Dahle CE, Weiner GJ. T-cell activation induced by anti/CDs anti-B-cell lymphoma monoclonal antibody is enhanced by pretreatment of lymphoma cells with CD40 ligand [J]. Cancer Immunol Immunother, 1997,45:174~179
  • 7[7]Schwaab T, Lewis LD, Gole BF, et al. Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RIX antiHER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu [J]. J Immunother, 2001,24(1):79~87
  • 8[8]Manzke O, Tesch H, Borchmann P, et al. Locoregional treatment of low-grade B-cell lymphoma with CD3x CD19 bispecitic antibodies and CD28 costimulation. I Clinical phaseI evaluation [J]. Int J Cancer, 2001,91(4):508~515
  • 9[9]Koelemij R, Kuppen PJK, van de Velde CJH, et al. Bispecific antibodies in cancer therapy, from the laboratory to the clinic [J]. J Immunother, 1999, 22(6):514~524
  • 10王力民,万文徽,陆良军,董志伟.介导多种胃癌杀伤效应的双功能抗体[J].中华肿瘤杂志,1994,16(2):83-87. 被引量:8

二级参考文献6

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部